Gsk (GSK) Equity Income (2009 - 2026)
Gsk (GSK) recorded Equity Income of -$2.69 million in the quarter ended Sep 30, 2026, compared with $5.4 million a year earlier.
Powered by 
Analysis
Gsk (GSK) Equity Income (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's Equity Income came in at $15.95 billion as of Sep 30, 2026, up 10.3% year-over-year; for the year ended Dec 31, 2025, it came in at $1.32 million.
- Annual Equity Income has a five-year compound annual growth rate of -50.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Equity Income came in at -$3.83 million in the year ended Dec 31, 2024, -$6.22 million in the year ended Dec 31, 2023, $3.89 billion in the year ended Dec 31, 2022 (+1.0%) and $3.85 billion in the year ended Dec 31, 2021.
- The figure for the quarter ended Sep 30, 2026 is the lowest quarterly Equity Income since the quarter ended Dec 31, 2020.
- On a year-over-year basis, Equity Income rose in five of the last six quarters, with an average decline of 3.2%.
- Peak year-over-year performance for Equity Income in the last five years was growth of 578.6% in the quarter ended Sep 30, 2022, against a decline of 99.8% in the quarter ended Sep 30, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.98 billion (quarter ended Jun 30, 2026), $2.76 billion (quarter ended Mar 31, 2026) and $10.22 billion (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,263.50 Bn | 1,237.12 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 655.05 Bn | 574.91 Bn | 17.30 Bn | - |
| 3 | AbbVie | 512.00 Bn | 485.11 Bn | 12.70 Bn | - |
| 4 | Merck | 368.57 Bn | 368.57 Bn | - | - |
| 5 | Novartis Ag | 313.61 Bn | 286.85 Bn | - | - |
| 6 | Astrazeneca | 290.22 Bn | 263.91 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 252.64 Bn | 208.04 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 212.62 Bn | 212.62 Bn | - | - |
| 9 | Pfizer | 175.96 Bn | 122.60 Bn | 10.94 Bn | - |
| 10 | Gsk | 99.60 Bn | 82.45 Bn | 8.73 Bn | -2.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.69 Mn |
| Jun 30, 2026 | 2.98 Bn |
| Mar 31, 2026 | 2.76 Bn |
| Dec 31, 2025 | 10.22 Bn |
| Sep 30, 2025 | 3.23 Bn |
| Jun 30, 2025 | 2.75 Bn |
| Mar 31, 2025 | 2.52 Bn |
| Dec 31, 2024 | 9.18 Bn |
| Sep 30, 2024 | 2.84 Bn |
| Jun 30, 2024 | 2.45 Bn |
| Dec 31, 2023 | 6.59 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 18.32 Bn |
| Sep 30, 2022 | 12.80 Bn |
| Jun 30, 2022 | 1.23 Bn |
| Mar 31, 2022 | 2.91 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.89 Bn |
API Access
Gsk Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();